Data-Driven Participant Recruitment: Findings from the Alzheimer's Disease Neuroimaging Initiative 3

C Barger1, J Fockler, W Kwang

  • 1Charissa Barger, Alzheimer's Therapeutic Research Institute, University of Southern California (USC) San Diego, CA, USA, charissa.barger@syneoshealth.com, 213-253-8387.

Summary

Effective Alzheimer's disease (AD) clinical trial recruitment requires measurable methods. Tracking recruitment tactics, like those used in the Alzheimer's Disease Neuroimaging Initiative (ADNI3), can improve participant enrollment.

Related Concept Videos